Drug Profile
Losartan/thioctic acid
Alternative Names: Alpha lipoic acid/losartan; INV-144; Losartan/alpha lipoic acid; Thioctic acid/losartanLatest Information Update: 07 Sep 2015
Price :
$50
*
At a glance
- Originator InVasc Therapeutics
- Class Antihypertensives; Biphenyl compounds; Imidazoles; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Antioxidants; Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetic nephropathies
Most Recent Events
- 07 Sep 2015 No recent reports on development identified - Phase-II for Diabetic nephropathies in USA (PO)
- 01 Jul 2012 InVasc Therapeutics completes a phase I/II trial in Diabetic nephropathies in USA (NCT01398423)
- 02 Apr 2012 InVasc Therapeutics completes enrolment in its phase II trial for Diabetic nephropathies in USA (NCT01398423)